SEC Company Response from SS Innovations International, (SSII) — Jul 3, 2019

SS Innovations International, Inc.
Date: July 3, 2019 · CIK: 0001676163 · Accession: 0001213900-19-012008

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-216054

Referenced dates: June 27, 2019

Date

July 3, 2019

Author

Not clearly detected

Form

CORRESP

Company

SS Innovations International, Inc.

Letter

AVRA MEDICAL ROBOTICS, INC.

3259 Progress Drive Suite 112A

Orlando, FL 32826

July 3, 2019

Via EDGAR

Securities and Exchange Commission

Division of Corporation Finance

Mail Stop 3030

100 “F” Street, N.E.

Washington, D.C. 20549-3629

Attention: Ms. Jeanne Bennett

Mr. Gary Todd

Re: AVRA Medical Robotics, Inc. (the “Company”)

Form 10-K for the Fiscal Year Ended December 31,

Filed April 16, 2019

File No. 333-216054

Ladies and Gentlemen:

In response to the comment set forth in the Staff’s letter dated June 27, 2019, we file herewith Form 10-K/A Amendment No. 1 to the Company’s 2018 Annual Report on Form 10-K, in which we have revised Item 9A. Controls and Procedures as requested by the Staff.

If you have any further questions or comments, kindly contact the undersigned at (407) 956-2250 or our counsel, Dale S. Bergman, Esq. of Gutiérrez Bergman Boulris, PLLC at (305) 358-5100.

Very truly yours,
AVRA MEDICAL ROBOTICS, INC.

Show Raw Text

CORRESP
1
filename1.htm

AVRA MEDICAL ROBOTICS, INC.

3259 Progress Drive Suite 112A

Orlando, FL 32826

July 3, 2019

Via EDGAR

Securities and Exchange Commission

Division of Corporation Finance

Mail Stop 3030

100 “F” Street, N.E.

Washington, D.C. 20549-3629

 Attention: Ms. Jeanne Bennett

Mr. Gary
Todd

 Re: AVRA Medical Robotics, Inc. (the “Company”)

Form 10-K for the Fiscal Year Ended December 31,
2018

Filed
April 16, 2019

File
No. 333-216054

Ladies and Gentlemen:

In response to the comment set forth in
the Staff’s letter dated June 27, 2019, we file herewith Form 10-K/A Amendment No. 1 to the Company’s 2018 Annual Report
on Form 10-K, in which we have revised Item 9A. Controls and Procedures as requested by the Staff.

If you have any further questions or comments,
kindly contact the undersigned at (407) 956-2250 or our counsel, Dale S. Bergman, Esq. of Gutiérrez Bergman Boulris, PLLC
at (305) 358-5100.

Very truly yours,

AVRA MEDICAL ROBOTICS, INC.

    By:
    /s/ Barry F. Cohen

    Barry F. Cohen

    Chief Executive Officer

SecProbe.io